Dr. Andrew Kingman, MD
What this data tells you about Dr. Kingman
Dr. Andrew Kingman is an urology physician in San Angelo, TX, with 16 years in practice. Based on federal Medicare data, Dr. Kingman performed 4,574 Medicare services across 1,709 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kingman received a total of $4,080 from 28 pharmaceutical and/or device companies across 175 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kingman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,741 | $18 | $33 |
| Office visit, established patient (30-39 min) | 608 | $89 | $218 |
| Blood draw (venipuncture) | 416 | $8 | $8 |
| Unclassified drugs | 272 | $501 | $1,028 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 229 | $129 | $418 |
| Office visit, established patient (20-29 min) | 190 | $67 | $148 |
| Ceftriaxone antibiotic injection | 177 | $0 | $10 |
| Placement of hormone pellet under skin | 176 | $72 | $278 |
| Diagnostic exam of bladder and urethra using an endoscope | 169 | $165 | $440 |
| New patient office visit (45-59 min) | 103 | $106 | $319 |
| Drug injection, under skin or into muscle | 99 | $11 | $50 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 40 | $25 | $95 |
| Insertion of stent in ureter using an endoscope | 38 | $78 | $1,442 |
| Initial hospital admission, moderate complexity | 36 | $94 | $268 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 29 | $54 | $209 |
| Hospital follow-up visit, moderate complexity | 29 | $62 | $141 |
| New patient office visit (30-44 min) | 21 | $69 | $209 |
| Biopsy of prostate gland | 19 | $90 | $446 |
| Ultrasound scan of pelvic region through rectum | 19 | $23 | $215 |
| Shock wave crushing of kidney stones | 18 | $414 | $4,670 |
| Injection, garamycin, gentamicin, up to 80 mg | 18 | $2 | $9 |
| Flu vaccine, high-dose | 16 | $62 | $63 |
| Flu vaccine administration | 16 | $17 | $17 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 15 | $207 | $874 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 15 | $336 | $1,393 |
| PSA test (prostate cancer screening) | 15 | $11 | $88 |
| Removal or manipulation of stone in ureter or kidney using an endoscope | 14 | $247 | $1,250 |
| Hospital follow-up visit, high complexity | 14 | $86 | $204 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 11 | $552 | $2,998 |
| X-ray of abdomen, 1 view | 11 | $15 | $69 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kingman is a clinical cardiology specialist, with above-average Medicare volume (top 26% in TX), and low-engagement industry engagement, with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kingman experienced with denosumab injection (prolia/xgeva)?
Does Dr. Kingman receive payments from pharmaceutical companies?
How do Dr. Kingman's costs compare to other urology physicians in San Angelo?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology